Q&A: Yared Hits The Ground Running

In an interview to discuss his initial experience as chairman of AdvaMed, Nadim Yared tells Medtech Insight his priority is repealing the medical device excise tax regardless of how such a repeal may affect enrollments in an ACA repeal. Also, while some in industry have expressed concern about the Trump administration's unpredictable nature, Yared says AdvaMed is suited to handle the shifting political winds.